The offset effect of pharmaceutical innovation: A review study

  • Néboa Zozaya University of Las Palmas de Gran Canaria, Las Palmas, Spain
  • Bleric Alcalá Department of Health Economics, Weber, Madrid, Spain
  • Jhon Galindo Department of Health Economics, Weber, Madrid, Spain
Keywords: Pharmaceutical innovation, drugs, offset effect, savings, costs, economic impact

Abstract

It is well known that pharmaceutical innovation has improved the health and quality of life of patients. It is however sometimes forgotten that new drugs also have the potential of improving the efficiency and the sustainability of the healthcare system. The objective of this review is to shed light on the magnitude of the offset effect that drugs may have in the realm of the healthcare system and for society as a whole. A narrative literature review was carried out. This review demonstrated that a growing body of literature has tried to measure the magnitude of the offset effect associated with pharmaceutical innovation, both at the aggregate level and for different diseases. There is evidence that the aggregate use of new drugs can generate net savings to the healthcare system and to society, as they may release both healthcare and non-healthcare resources for alternative uses. A high degree of heterogeneity in the magnitude of the effect has been found across different pathologies and different types of drugs.
Published
2019-09-14
How to Cite
ZozayaN., AlcaláB., & GalindoJ. (2019). The offset effect of pharmaceutical innovation: A review study. Global & Regional Health Technology Assessment, 6(1). https://doi.org/10.33393/grhta.2019.454